pentobarbital has been researched along with Labyrinth Diseases in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Labyrinth Diseases: Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JONGKEES, LB | 1 |
| PHILIPSZOON, AJ | 1 |
| Bosatra, A | 1 |
| Russolo, M | 1 |
2 other studies available for pentobarbital and Labyrinth Diseases
| Article | Year |
|---|---|
ELECTRONYSTAGMOGRAPHY.
Topics: Acceleration; Alcohols; Biomedical Research; Chlorpromazine; Deafness; Ear, External; Electric Stimu | 1964 |
Directional hearing, temporal order and auditory pattern in peripheral and brain stem lesions.
Topics: Auditory Pathways; Auditory Perception; Brain Diseases; Brain Stem; Hearing; Hearing Disorders; Hear | 1976 |